LentiGuide-puro-NLS-mCherry Citations (3)

Originally described in: The shieldin complex mediates 53BP1-dependent DNA repair.
Noordermeer SM, Adam S, Setiaputra D, Barazas M, Pettitt SJ, Ling AK, Olivieri M, Alvarez-Quilon A, Moatti N, Zimmermann M, Annunziato S, Krastev DB, Song F, Brandsma I, Frankum J, Brough R, Sherker A, Landry S, Szilard RK, Munro MM, McEwan A, Goullet de Rugy T, Lin ZY, Hart T, Moffat J, Gingras AC, Martin A, van Attikum H, Jonkers J, Lord CJ, Rottenberg S, Durocher D Nature. 2018 Aug;560(7716):117-121. doi: 10.1038/s41586-018-0340-7. Epub 2018 Jul 18. PubMed Journal

---

Articles Citing LentiGuide-puro-NLS-mCherry

Articles
WEE1 inhibitors synergise with mRNA translation defects via activation of the kinase GCN2. Wilson JCJ, Zhu J, Vinciauskaite V, Lloyd EG, Lam S, Hart A, Goh CG, Bou-Dagher F, Razumkov H, Kobel L, Kontarakis Z, Fielden J, Schlapansky MF, Loizou JI, Villunger A, Corn JE, Biffi G, Masson GR, Marciniak SJ, Bader AS, Jackson SP. Nat Commun. 2025 Oct 9;16(1):8983. doi: 10.1038/s41467-025-64050-5. PubMed
A Cre-mediated copy number variant compromises the reliability of a LoxP-STOP-LoxP-PLAG1 driven brain tumor model. Vaillant J, Pal S, Muller J, Wittmann A, Boakye-Yiadom A, Sievers P, Zimmer P, Schoof M, Schelb F, Hofmann N, Keck MK, Fabian T, Schuller U, Zuckermann M, Beroukhim R, Bandopadhayay P, Jones DTW, Kutscher LM. Neurooncol Adv. 2025 Dec 9;8(1):vdaf251. doi: 10.1093/noajnl/vdaf251. eCollection 2026 Jan-Dec. PubMed
Genome-Wide CRISPR Screens Identify ABCG2-Mediated Drug Resistance to the Threonine Tyrosine Kinase (TTK) Inhibitor CFI-402257 in Breast Cancer. Thu KL, Jafari S, Silvester J, Cruickshank J, Soria-Bretones I, Hodgson K, Tobin C, Haight J, Lau APY, Bray T, Wakeham D, Bray MR, Mak TW, Cescon DW. Int J Mol Sci. 2026 Mar 14;27(6):2665. doi: 10.3390/ijms27062665. PubMed

If you have published an article using this material, please email us at to have your article added to this page.